Skip to main content

Published locations for Switching from interferon beta-1a to alemtuzumab improves MS outcomes

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Switching from interferon beta-1a to alemtuzumab improves MS outcomes

User login

  • Reset your password
  • /content/switching-interferon-beta-1a-alemtuzumab-improves-ms-outcomes
  • /neurologyreviews/article/202084/multiple-sclerosis/switching-interferon-beta-1a-alemtuzumab-improves
  • /multiplesclerosishub/article/202084/multiple-sclerosis/switching-interferon-beta-1a-alemtuzumab
  • /neurology/article/202084/multiple-sclerosis/switching-interferon-beta-1a-alemtuzumab-improves-ms
  • /neurology/msresourcecenter/article/202084/multiple-sclerosis/switching-interferon-beta-1a
  • /clinicalneurologynews/article/202084/multiple-sclerosis/switching-interferon-beta-1a-alemtuzumab